Table 4.
Statistical analyses of Estrogen E2 (Pg/ml) and Estrogen receptor ER (ng/ml) in male patients group according to Sokal score
| Sokal score | |||
|---|---|---|---|
| < 0.8 Low risk | 0.8 – 1.2 intermediate risk | > 1.2 High risk | |
| Estrogen (pg/ml) | (n = 8) | (n = 7) | (n = 5) |
| Range | 16.20 – 45.90 | 10.90 – 46.20 | 15.10 – 34.20 |
| Mean ± SE | 26.34 ± 3.63 | 27.61 ± 5.12 | 25.98 ± 3.07 |
| p | 0.942 | ||
| p1 | 0.949 | ||
| p2 | 0.570 | ||
| p3 | 0.685 | ||
| ER | (n = 8) | (n = 7) | (n = 5) |
| Range | 0.87 – 5.61 | 1.50 – 8.20 | 1.05 – 2.20 |
| Mean ± SE | 2.66 ± 0.72 | 5.01 ± 0.91 | 1.57 ± 0.18 |
| Hp | 0.043* | ||
| p1 | 0.030* | ||
| p2 | 0.818 | ||
| p3 | 0.032* | ||
P: P value for Kruskal Wallis test for comparing E2 between the three categories, Sig.bet.grps was done using Post Hoc Test (Dunn's multiple comparisons test).Hp: Hp value for Kruskal Wallis test for comparing ER between the three categories, Sig.bet.grps was done using Post Hoc Test (Dunn's multiple comparisons test)
p1: p value comparing between < 0.8 and 0.8 – 1.2 p2: p value comparing between < 0.8 and > 1.2
p3: p value comparing between 0.8 – 1.2 and > 1.2 *: Statistically significant at p ≤ 0.05